Work

Allogeneic Transplant Outcomes in Imatinib-Refractory Chronic Myeloid Leukaemia (CML) Are Similar to Transplant Outcomes in Imatinib-Responsive/Imatinib-Naive CML and Appear To Be Predicted by the EBMT Risk Score.

Year: 2006

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v108.11.3155.3155

Authors: Steven Stylian, Eileen T. Fennelly, Jason P. Butler, James P. Morton, Robyn Western, Cheryl J. Hutchins, Geoff R. Hill, Simon T. Durrant, Glen A. Kennedy

Institution: Royal Brisbane and Women's Hospital

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W119150346

FWCI:

Cites:

Cited by:

Related to: 10